2SEVENTY BIO INC
2SEVENTY BIO INC logo
TSVT

2SEVENTY BIO INC (TSVT)

$14.450.35%

Market is closed
– opens on 8 PM, 09 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$13.9
Day's Range
$14.62
$9.91
52-Week Range
$34.0
1 month return7.79%
3 month return9.74%
1 year return53.31%
5 year return57.02%

Company Information

Its name, 2seventy bio, reflects why 2seventy bio does what 2seventy bio does - TIME. Cancer rips time away and its goal is to work at the maximum speed of translating human thought into action – 270 miles per hour — to give the people 2seventy bio serve more time. 2seventy bio is building the leading immuno-oncology cell therapy company, focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. With a deep understanding of the human body’s immune response to tumor cells and how to translate cell therapies into practice, 2seventy bio’s applying this knowledge to deliver next generation cellular therapies that focus on a broad range of hematologic malignancies, including the first FDA-approved CAR T cell therapy for multiple myeloma, as well as solid tumors. Its research and development is focused on delivering therapies that are designed with the goal to "think" smarter and faster than the disease. Importantly, 2seventy bio remains focused on accomplishing these goals by staying genuine and authentic to its "why" and keeping its people and culture top of mind every day.
Organization2SEVENTY BIO INC
Employees437
CEOMr. Nick Leschly
IndustryHealthcare

Analyst Recommendation

based on 3 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 3 Wall street analysts offering stock ratings for 2SEVENTY BIO INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 108.79%

Current

$14.45

Target

$30.17

Recommendation Trend

Based on 3 analyst

Current1M Ago3M Ago
Buy
3
11
11
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
546.0M
Book Value
$8.52
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-11.94
Wall Street Target Price
30.17

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1.88
Enterprise Value
558.4M
Enterprise Value/Revenue
10.87
Enterprise Value/Ebitda
-1.92

Technicals

50 Day MA
15.23
200 Day MA
14.55

Institutional Holdings

Wellington Management Company LLP

8.47%

BlackRock Inc

6.81%

Vanguard Group Inc

6.21%

EcoR1 Capital, LLC

6.17%

State Street Corporation

6.07%

Baker Bros Advisors LP

5.44%

Discover more

Frequently Asked Questions

What is 2SEVENTY BIO INC share price today?

Can Indians buy 2SEVENTY BIO INC shares?

How can I buy 2SEVENTY BIO INC shares from India?

Can Fractional shares of 2SEVENTY BIO INC be purchased?

What are the documents required to start investing in 2SEVENTY BIO INC stocks?

What are today’s High and Low prices of 2SEVENTY BIO INC?

What are today’s traded volumes of 2SEVENTY BIO INC?

What is today’s market capitalisation of 2SEVENTY BIO INC?

What is the 52 Week High and Low Range of 2SEVENTY BIO INC?

How much percentage 2SEVENTY BIO INC is down from its 52 Week High?

How much percentage 2SEVENTY BIO INC is up from its 52 Week low?

What are the historical returns of 2SEVENTY BIO INC?

Who is the Chief Executive Officer (CEO) of 2SEVENTY BIO INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*